In the RADV Era, Healthcare AI Traceability Is No Longer Optional
- Dr. Dhini
- Apr 21
- 4 min read
TL;DR
Old Standard: Healthcare AI was measured by how much it surfaced. More output looked like progress.
What Changed: RADV made weak or unclear evidence a real audit and financial risk.
Hidden Cost: When evidence isn’t clear, work doesn’t disappear—it moves to manual review, chart chasing, and reviewer fatigue.
Key Insight: Accuracy alone isn’t enough if teams can’t quickly trace recommendations to evidence.
The Real Shift: This isn’t a model problem—it’s a workflow design problem.
Bottom Line: The goal is no longer more output, but accurate, defensible, audit‑ready decisions.
For years, many healthcare AI and risk adjustment tools were judged on one thing above all else: could they surface more opportunity?
If a system produced more suspects, more diagnoses, or more output, that was often enough to get attention. Volume was treated as progress.
That standard is getting harder to defend.
Today, the more important question is no longer whether a system can identify a possible condition.
It is whether an organization can clearly understand why it surfaced, what evidence supports it, and whether that evidence is visible enough to verify without redoing the work manually.
That is the shift toward healthcare AI traceability.
And in the RADV era, it is no longer optional.
RADV Changes the Burden of Proof
CMS’s RADV program exists to recover improper risk adjustment payments when diagnoses are not supported by the medical record.
With extrapolation applied, a small number of unsupported diagnoses can now create population-level financial risk, not just isolated errors.
CMS has also signaled a more aggressive audit posture, increasing review volume and audit coverage.
You do not need to be a compliance expert to understand what this means operationally.
When audit pressure rises, the cost of weak evidence rises with it.
A recommendation that once felt “probably fine” now has to meet a higher bar:
Can it be defended clearly, quickly, and consistently under scrutiny?
That is what RADV changes.
It raises the burden of proof.
The Black-Box Problem Is Not Theoretical
In healthcare AI, black-box systems are often framed as a philosophical issue. Transparency. Explainability. Trust.
But in a real risk adjustment workflow, the problem is not abstract.
It is operational.
If a system surfaces a diagnosis without clearly showing the supporting note, sentence, lab, or documentation, the burden of validation does not go away.
It moves.
The work does not disappear. It moves downstream to the human reviewer.
And the organization still pays for it:
Chart chasing
Manual verification
Reviewer fatigue
Inconsistent decisions
Slower follow-through
Weaker confidence in submissions
A workflow can look intelligent on the surface while preserving the hardest part of the work underneath.
This is why the black-box problem in healthcare AI is not just about models.
It is a workflow design problem.
If the output cannot be traced, it cannot be trusted in a high-scrutiny environment.
Why Traceability Matters More Under V28
The V28 transition has raised the bar on evidence quality and specificity.
Fewer payment-mapped ICD-10 codes and tighter model logic mean broad suspecting is far less valuable when poorly supported.
Organizations are now operating under two simultaneous pressures:
A stricter model environment (V28)
A stricter audit environment (RADV)
Together, they redefine what a high-quality risk adjustment workflow looks like.
Under a looser environment, teams could tolerate high-volume suspect lists.
Now, that same approach creates noise before it creates value.
If reviewers still have to search for evidence, reconstruct context, and decide what is defensible, the system is not meaningfully reducing burden.
Healthcare AI traceability is what turns a possibility into an actionable recommendation.
Without it, the workflow still depends on manual rescue.
Accuracy Without Traceability Is Not Enough
This is a point the market still underestimates.
A model can appear highly capable. It can generate plausible output. It can look impressive in a demo.
But if an organization cannot move quickly from recommendation to evidence,
the practical value of that intelligence drops sharply in real workflows.
This is where complexity shows up, not in the model, but in the people who rely on it.
Clinicians need medical validity. Coding and compliance need supportability. Operations need efficiency. Executives need defensibility.
When reasoning is not visible, confidence breaks down.
And when confidence breaks down, adoption follows.
This is why the principle is simple:
Accuracy without traceability is not enough. Because in healthcare, output is not the end of the job. The system must also support verification, adoption, and audit readiness.
What Healthcare AI Traceability Should Look Like
Traceability does not require deep model transparency or technical explanations.
In practice, it is simpler than that.
Can a user answer a few critical questions immediately?
Why was this surfaced?
What evidence supports it?
Where exactly is that evidence?
Is it current and specific?
Is it worth acting on now?
If those answers are not clear, the workflow is incomplete.
This is what strong healthcare AI traceability enables:
Less time hunting
More time deciding
Less ambiguity
More consistency
Stronger trust across teams
That is far more valuable than high output volume that leaves proof work to the user.
The Real Issue Is Workflow Design
What RADV and V28 expose is not just a documentation problem.
They expose a workflow design problem.
Too many systems were built around generating more opportunities.
But today, value comes from helping teams act on the right opportunities with clear evidence and less waste.
That shift changes how tools should be evaluated:
Is evidence immediately visible?
Does the system reduce validation work or shift it?
Does it prioritize defensible opportunities?
Can stakeholders trust it for their own needs?
Will it hold up under RADV scrutiny?
These are the questions that define modern risk adjustment workflows.
A More Useful Standard for Healthcare AI
The market is moving beyond output volume toward a more mature standard.
Not whether a system can find something.
But whether it can support action with enough clarity that people can trust it, use it, and defend it.
In the RADV era, healthcare AI traceability is no longer optional.
It is not a feature. It is not a preference. It is not a philosophy.
It is part of risk management.
And it is increasingly what separates high-performing workflows from those that simply create more work.
What This Means Now
In this environment, healthcare organizations should expect more than intelligent output.
They should expect workflows that make evidence visible, reduce validation burden, and support defensible decisions across teams.
That is the practical meaning of healthcare AI traceability.
And in the RADV era, it is one of the clearest indicators of whether a workflow is truly ready for what comes next.
Comments